Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederinvestor.lilly.com
Eli Lilly and Company News Releases
Get the latest updates from Eli Lilly and Company News Releases directly as they happen.
Follow now 98 followers
Latest posts
Last updated about 11 hours ago
Lilly plans to expand Purdue University collaboration with up to a $250 million investment to accelerate pharmaceutical innovation
about 12 hours ago
INDIANAPOLIS and WEST LAFAYETTE, Ind. , May 9, 2025 /PRNewswire/ -- Eli...
Lilly announces transitions in executive leadership
1 day ago
INDIANAPOLIS , May 8, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE...
Lilly declares second-quarter 2025 dividend
4 days ago
INDIANAPOLIS , May 5, 2025 /PRNewswire/ -- The board of directors of...
Lilly to participate in Bank of America Securities 2025 Healthcare Conference
7 days ago
INDIANAPOLIS , May 2, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY)...
Lilly reports first-quarter 2025 financial results and highlights pipeline momentum
9 days ago
Revenue in Q1 2025 increased 45% to $12.73 billion driven by volume...
Lilly confirms date and conference call for first-quarter 2025 financial results announcement
22 days ago
INDIANAPOLIS , April 17, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE...
Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
23 days ago
Orforglipron is the first small molecule GLP-1 to successfully complete a Phase...
Statement: Lilly has no affiliation with hims & hers
about 1 month ago
INDIANAPOLIS, April 1, 2025 – Eli Lilly and Company (NYSE: LLY) has...
Lilly's lepodisiran reduced levels of genetically inherited heart disease risk factor, lipoprotein(a), by nearly 94% from baseline at the highest tested dose in adults with elevated levels
about 1 month ago
In Phase 2 ALPACA results, lepodisiran significantly reduced levels of genetically inherited...
Lilly’s statement about the CHMP opinion issued for donanemab
about 1 month ago
INDIANAPOLIS, March 28, 2025 -- European Medicines Agency’s (EMA) Committee for Medicinal...
LillyDirect platform expands to facilitate access to Alzheimer's disease care
about 1 month ago
New tools to connect with independent in-person and telehealth providers specializing in...
Lilly announces details of presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting
about 2 months ago
INDIANAPOLIS , March 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE...